Transcranial Theranostic Ultrasound for Pre-Planning and Blood-Brain Barrier Opening: A Feasibility Study Using an Imaging Phased Array In Vitro and In Vivo.
Authors: Batts A, Ji R, Kline-Schoder A, Noel R, Konofagou E
Focused ultrasound (FUS) for blood-brain barrier (BBB) opening is a safe, reversible and non-invasive strategy for targeted drug delivery to the brain, however extensive pre-planning strategies are necessary for successful FUS-mediated BBB opening through the structurally complex primate skull. This study aims to demonstrate a pre-planning pipeline consisting of transcranial simulations and in vitro experimentation used to inform synchronous BBB opening and power cavitation imaging (PCI) with a single theranostic ultrasound (TUS) phased array. Acoustic wave propagation simulation findings of pressure attenuation and focal shift through clinical-CT and micro-CT-based primate skull models were compared, while the latter were used to determine the impact of beam steering angle on focal shift and pressure attenuation. In vitro experimentation with a channel phantom enabled characterization of skull-induced receive focal shift (RFS), while in vivo BBB opening and PCI using in silico and in vitro pre-planning information was conducted using a custom Verasonics/MATLAB script. Simulations confirmed steering angle dependent transcranial focal shift and pressure attenuation, while in vitro experiments revealed minimal (0.30-1.50 mm) skull-induced RFS. In vivo rodent experiments with overlaid primate skull fragments demonstrated successful TUS-mediated BBB opening and spatially correlated power cavitation images (PCI) with regions of BBB opening on T<sub>1</sub>-weighted magnetic resonance images (MRI). We demonstrated the feasibility for TUS-mediated BBB opening in vivo using in silico and in vitro pre-planning information. TUS as an ultrasound-guided modality for BBB opening could serve as a promising alternative to current FUS-mediated BBB opening configurations in the clinic.
Introduction
Purpose
Drug delivery with BBB opening
Study Objective
To demonstrate a pre-planning pipeline of transcranial simulations and in vitro experiments to inform synchronous blood–brain barrier opening and power cavitation imaging using a single theranostic ultrasound phased array.
Animal model / Human subject
Mouse, C57BL/6, adult, male
Disease model
Healthy
Targeted brain region(s)
Both Hemispheres
Outcomes and Safety
Summary of Outcomes
Theranostic ultrasound using a single phased array achieved spatially localized BBBO in vivo correlated with power cavitation imaging and MRI. Simulations demonstrated steering-angle-dependent focal shift and pressure attenuation, while in vitro experiments showed minimal skull-induced receive focal shift
Duration of biological effect
7 h
Safety-related matter
BBB opening was reversible with closure observed by 7 hours.
Brain Region
Ultrasound Parameters
Ultrasound instrument
P4-1 phased array transducer (ATL, Philips, Amsterdam, Netherlands). Verasonics research ultrasound system (Vantage 256, Verasonics Inc., Kirkland, WA, USA)
FUS Frequency
1.5 MHz
FUS Pressure
0.45 MPa
FUS Mode
pulsed
Pulse duration
2 us
Duration of a single FUS session
120 s
Focal Characteristics
Focal depth: 35 mm; Focal length: None; Aperture size: None
Treatment frequency
Single
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search